Assignee
SLA PHARMA AG
CH·8 granted patents·7 pending applications·22 citations·filing 1997–2022
Top patents by PatentIndex Score
15 records- 0172US10709689B2Pharmaceutical compositionSLA PHARMA AG·Filed 2014·Granted Jul 14, 2020·0 cites·5 claims
- 0271US7781444B2Pharmaceutical composition for treating fecal incontinence and anal itchSLA PHARMA AG·Filed 2007·Granted Aug 24, 2010·0 cites·4 claims
- 0365US11013709B2Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patientsSLA PHARMA AG·Filed 2019·Granted May 25, 2021·0 cites·15 claims
- 0463US10653671B2Topical pharmaceutical compositions for treatment of skin damageSLA PHARMA AG·Filed 2013·Granted May 19, 2020·0 cites·15 claims
- 0562US10881640B2Topical pharmaceutical compositions for treatment of pilonidal sinus woundsSLA PHARMA AG·Filed 2016·Granted Jan 5, 2021·0 cites·12 claims
- 0659US6635678B1Pharmaceutical composition for treating fecal incontinenceSLA PHARMA AG·Filed 1997·Granted Oct 21, 2003·17 cites·7 claims
- 0758US2021251935A1Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patientsSLA PHARMA AG·Filed 2021·Application pending·0 cites
- 0854US2006240123A1Pharmaceutical compositionSLA PHARMA AG·Filed 2003·Application pending·0 cites
- 0954US2019374496A1Treatment with highly purified eicosapentaenoic acid as free fatty acid improves inflammation, affects colonic differentiation markers and microbiota in patients with ulcerative colitisSLA PHARMA AG·Filed 2019·Application pending·0 cites
- 1053US7928146B2Pharmaceutical composition for treating fecal incontinence and anal itchSLA PHARMA AG·Filed 2003·Granted Apr 19, 2011·0 cites·6 claims
- 1153US2023144875A1Highly purified eicosapentaenoic acid, as free fatty acid for treatment of coronaviruses and specifically novel coronavirus-19 (covid-19)SLA PHARMA AG·Filed 2021·Application pending·0 cites
- 1252US2024252468A1Treatment of tunneling wounds using metronidazole-containing compositionsSLA PHARMA AG·Filed 2022·Application pending·0 cites
- 1349US2004028752A1Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blockerSLA PHARMA AG·Filed 2002·Application pending·0 cites
- 1446US2019175558A1Topical pharmaceutical compositions for treatment of tissue damageSLA PHARMA AG·Filed 2018·Application pending·0 cites
- 1538US8048875B1Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blockerSLA PHARMA AG·Filed 1997·Granted Nov 1, 2011·5 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when SLA PHARMA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →